← Back to Search

Behavioral Intervention

Naming Treatment for Aphasia

N/A
Waitlist Available
Led By Erica L Middleton, PhD
Research Sponsored by Albert Einstein Healthcare Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment, approximately one-week and one-month post-treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to develop and test a new treatment for aphasia, a language disorder commonly following a stroke. The treatment involves practice sessions to help individuals with aphasia retrieve known words more easily. The

Who is the study for?
This trial is for adults who have had a stroke at least 6 months ago and primarily speak English. It's designed to help those with aphasia, which is a language disorder affecting speech and comprehension.
What is being tested?
The study tests a treatment called 'Criterion-learning practice' aimed at improving word retrieval in people with aphasia. The treatment involves exercises that focus on correct word usage, spread out over multiple sessions.
What are the potential side effects?
Since the intervention involves language practice rather than medication, traditional side effects are not expected. Participants may experience fatigue or frustration during the learning process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment, approximately one-week and one-month post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment, approximately one-week and one-month post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Trained comprehension items (Experiment 4)
Trained naming items (Experiment 1)
Trained naming items (Experiment 2)
+5 more
Other study objectives
Connected speech output performance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Criterion-learning practiceExperimental Treatment1 Intervention
This is a single-arm study.

Find a Location

Who is running the clinical trial?

Albert Einstein Healthcare NetworkLead Sponsor
64 Previous Clinical Trials
868,619 Total Patients Enrolled
2 Trials studying Aphasia
57 Patients Enrolled for Aphasia
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
354 Previous Clinical Trials
181,645 Total Patients Enrolled
39 Trials studying Aphasia
2,734 Patients Enrolled for Aphasia
Thomas Jefferson UniversityOTHER
464 Previous Clinical Trials
175,659 Total Patients Enrolled
Erica L Middleton, PhDPrincipal InvestigatorAlbert Einstein Healthcare Network
~60 spots leftby Aug 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top